Publications

With an Impact Factor of 23.9, Blood is the most cited peer-reviewed publication in the field of hematology with over 168,000 citations in 2025. It is the premier journal of the American Society of Hematology and since 1946 it has provided an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology.

Blood Advances is a top ranked hematology journal with a 2025 Impact Factor of 7.7 and publishes more peer-reviewed hematology research than any other scientific journal. This open-access journal covers all aspects of hematology, including original research and important community resources such as the ASH Clinical Guidelines.

Blood Global Hematology publishes local adaptions of clinical guidelines, epidemiology and public health analyses, and opinion articles that address hematologic issues of global impact. This open access, online-only journal aims to improve the lives of patients worldwide. Blood Global Hematology provides a supportive publication experience for authors, particularly those from regions currently underrepresented in medical literature.

Blood Immunology & Cellular Therapy focuses on research in basic, translational, and clinical investigations related to cellular and non-cellular immunotherapies for hematological conditions and the underlying immunology. The scope of this open access, online-only journal includes non-cellular therapies like vaccinations, monoclonal antibodies, antibody-drug conjugates, and immune checkpoint inhibitors, and gene therapies.

Blood Neoplasia is an open-access, online-only journal that publishes original research on hematologic malignancies and associated disorders, including leukemia, lymphoma, multiple myeloma, Waldenström macroglobulinemia, hemophagocytic lymphohistiocytosis, myeloproliferative neoplasms, measurable residual disease, and precursor conditions.

Blood Red Cells & Iron welcomes articles with significant clinical and/or scientific impact on the topics of red blood cells and research relevant to hematologic diseases involving erythroid lineage. Other topics in this open access, online-only journal include inherited and acquired anemias, nutritional anemias, sickle cell disease, thalassemia, malaria, immune-mediated anemias, and normal and many other topics.

Blood Vessels, Thrombosis & Hemostasis focuses on clinical and mechanistic aspects of normal and abnormal hemostasis and vascular function, including acquired bleeding and thrombotic disorders. Other topics published in this open-access, online-only journal include disorders involving the venous, arterial, and microvasculature.

ASH’s bimonthly member newsletter, The Hematologist: ASH News and Reports, is designed for the broad constituency of ASH, ranging from basic scientists to practicing clinicians. The Hematologist updates readers about important breakthroughs, trials, and literature; publishes expert advice for clinicians; and spotlights the latest ASH programs and initiatives.

ASH Clinical News, a monthly news magazine specifically designed to appeal to clinical practitioners in hematology and oncology, provides timely updates in the field by reporting on key medical meetings, clinical trials, innovative technology, and influential papers in the literature. Regular features include clinical consults, interviews with leaders in various hematology subspecialties, patient education information, news about individual ASH members, and updates on Society initiatives.

The official newspaper of the ASH annual meeting, ASH News Daily highlights each day’s sessions and events.